Institutional Ownership
Amedisys Inc
CUSIP 023436108COMAMEDQ1 2026
13D / 13G Filings
26
Schedule 13D/13G on record
Beneficial Filers
8
Distinct reporting persons
Largest Stake
13.5%
Max % of class reported
Institutional Holders
1
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
26 filings · latest Nov 14, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Nov 14, 2025 | Pentwater Capital Management LP | 13G/A | — | 49 | SEC |
| 2 | Nov 14, 2025 | The Goldman Sachs Group, Inc. | 13G/A | 11.0% | 190 | SEC |
| 3 | Aug 14, 2025 | Pentwater Capital Management LP | 13G | 5.2% | 1.72M | SEC |
| 4 | Aug 12, 2025 | The Goldman Sachs Group, Inc. | 13G | 11.0% | 1.77M | SEC |
| 5 | Feb 13, 2024 | Vanguard Group Inc | 13G/A | 9.9% | 3.22M | SEC |
| 6 | Feb 12, 2024 | Flynn James E | 13G/A | — | — | SEC |
| 7 | Feb 8, 2024 | Wellington Management Group LLP | 13G/A | — | — | SEC |
| 8 | Jan 24, 2024 | Blackrock Inc. | 13G/A | 9.1% | 2.96M | SEC |
| 9 | Jul 6, 2023 | Jpmorgan Chase & Co | 13G/A | 2.3% | 774.4K | SEC |
| 10 | May 18, 2023 | Flynn James E | 13G | 5.5% | 1.79M | SEC |
16 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Amedisys Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Huntington National Bank | 1 | $101 |